Page 2 - உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி Today - Breaking & Trending Today

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis


/ April 20, 2021 /
Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced today that CARB-X has awarded the company up to $11.6 million in non-dilutive funding. This funding will support the development of a near-patient and rapid diagnostic platform for sepsis - specially focused on addressing the unique needs of neonatal and pediatric populations.
The CARB-X award consists of $3.9 million in initial funding with up to $7.7 million of milestone-based funding. CARB-X, a global non-profit partnership, provides funding and support for projects that target drug-resistant bacteria deemed Serious or Urgent on the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Resistant Threats list or Critical or High on the World Health Organization s Priority Bacterial Pathogens list. ....

North Carolina , United States , United Kingdom , Emily Mcloughlin , Vamsee Pamula , Richard West , Us Centers For Disease , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Baebies Inc , Us Department Of Health , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , World Health Organization Priority Bacterial Pathogens , Biomedical Advanced Research , Human Services , Boston University , Disruptive Technology Award , Development Authority , Germany Federal Ministry Of Education , United Kingdom Government Department Of Health , Office Of The , Us National Institutes Of Health , Disease Control , Antibiotic Resistant Threats ,

GARDP welcomes additional funding from UK to develop new treatment for gonorrhoea


GARDP welcomes additional funding from UK to develop new treatment for gonorrhoea
The UK government has announced an additional £1.5 million of funding to develop a new treatment for gonorrhoea.
From:
12 February 2021
This investment, on top of £3.5 million committed in 2019, will support the Global Antibiotic Research and Development Partnership (
GARDP) in the development and availability of zoliflodacin, a novel antibiotic, which is currently being assessed as part of a global phase 3 trial for safety and effectiveness as a treatment for gonorrhoea.
This new antibiotic has the potential to treat drug resistant gonorrhoea and is one of the few antibiotics in development specifically for the disease, an important consideration to ensure the treatment remains effective for generations to come. ....

United Kingdom , South Africa , Seamus Obrien , Innovation Fund , Global Antibiotic Research , Department For Health , Global Antimicrobial Resistance Innovation Fund , World Health Organization , Sustainable Development Goals , Development Partnership , Social Care , Antimicrobial Resistance Innovation Fund , United Kingdom Aid , One Health , Neglected Diseases , Sans Fronti , ஒன்றுபட்டது கிஂக்டம் , சீமஸ் ஓபிறீேன் , கண்டுபிடிப்பு நிதி , உலகளாவிய நுண்ணுயிர்க்கொல்லி ஆராய்ச்சி , துறை க்கு ஆரோக்கியம் , உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , நிலையான வளர்ச்சி இலக்குகள் , வளர்ச்சி கூட்டு , சமூக பராமரிப்பு ,